How to Decide Impurity Limits in Pharma | ICH Q3A, Q3B & Method Validation Explained

How to Decide Impurity Limits in Pharmaceutical Products? In this video, we explain in a simple and practical way how impurity limits are established in pharmaceutical analytical methods. You will learn about: ✅ How to decide impurity limits ✅ ICH Q3A and Q3B concepts ✅ Reporting, Identification & Qualification Thresholds ✅ Role of Maximum Daily Dose ✅ Impurity exposure calculation ✅ Organic impurities & degradation products ✅ Mutagenic impurities – ICH M7 overview ✅ Residual solvents – ICH Q3C ✅ Elemental impurities – ICH Q3D ✅ Impurity specification vs validation concentration ✅ How impurity limits connect with analytical method validation ✅ Practical examples for Pharma QC & AMV professionals This video is useful for Quality Control, Analytical Method Validation, Method Development, Stability, QA and Pharmaceutical professionals, as well as students preparing for pharma analytical interviews. ⚠️ Important: Final impurity specifications should always be established using the applicable current regulatory requirements, product-specific information and appropriate scientific/toxicological justification. If this video helps you, LIKE 👍, SHARE and SUBSCRIBE 🔔 for more practical Pharmaceutical Analytical Method Validation content. #ImpurityLimits #ICHGuidelines #PharmaceuticalAnalysis #MethodValidation #PharmaQC